Trial NCT01822496

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2013-00737
Secondary IDs: NCI-2013-00737 RTOG-1306 U10CA021661 U10CA180868

Last trial update was posted on 2019-08-05

MeSH Interventions

Albumin-Bound Paclitaxel Carboplatin Cisplatin Crizotinib Erlotinib Hydrochloride Etoposide Etoposide phosphate Paclitaxel Podophyllotoxin Tyrosine Kinase Inhibitors

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Stage III Non-Small Cell Lung Cancer AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Non-Small Cell Lung Cancer AJCC v7

Stopping Reasons

N/A

Limitations And Caveats

This study stopped accrual early due to unmet targeted accrual goals with 59 subjects accrued out of 234 planned.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID